PERSONALIZED GENOMICS MARKET ANALYSIS

Personalized Genomics MarketSize and Trends

The global personalized genomics market size is expected to reach US$ 27.77 Billion by 2030, from US$ 9.14 Billion in 2023, at a CAGR of 17.2% during the forecast period. Personalized genomics involves the sequencing and analysis of an individual’s unique genetic makeup to guide healthcare decisions. It empowers individuals with knowledge of their genetic risks and enables early diagnosis, preventive screening, tailored treatment plans, and lifestyle modifications based on personal genomes. The key drivers include declining costs of genomic sequencing, a focus on preventive medicine, and rising demand for personalized therapies.

Global Personalized Genomics Market Trends

• Partnerships to Advance Genomic Medicine: Collaborations between biopharma companies, technology firms, diagnostic laboratories, hospitals, and academic centers are accelerating innovation in genomic medicine. These partnerships allow access to diverse genomic datasets, optimize clinical trial design using biomarkers, and co-develop precision medicine tools. For instance, in June 2022, Ligandal Inc., a genetic medicine company, entered into a strategic partnership with Nanotronics a nanotechnology company to solidify optimization and quality in personalized genomic medicine delivery systems. This partnership enhances commercialization, develops, and provides next-generation technologies for gene therapy, peptide materials, nanomaterials, and the characterization of biological technologies.
• Integration with Digital Health Infrastructure: Genomic medicine is increasingly integrated with digital health tools like electronic health records, telemedicine, mobile apps, and wearables. This enables seamless data sharing and deeper insights through a holistic view of an individual’s genomic profile and healthcare history. For instance, wearables that continuously track heart rate, blood pressure and glucose levels provide phenotypic data that can power precision diagnosis. Cloud computing allows efficient storage and analysis of multi-omics data. Digital integration improves genomic test ordering, automated interpretation of results, and personalized recommendations. Telegenetics facilitates access to genetic counseling in remote areas. Thus, digital health convergence expands utility across the genomic testing workflow.
• Emphasis on Data Security and Privacy: Genomic data is extremely sensitive, it's critical to ensure cybersecurity and privacy. Organizations are enhancing data protection through encryption, blockchain-based systems, and strict access controls. Many countries, like Australia, U.K., and Canada, have passed genomic privacy laws to regulate the collection, storage, and sharing of genomic information. There is also a growing push towards greater transparency and providing patients with more control over their genomic data. Initiatives like the Global Alliance for Genomics and Health have defined best practices for responsible genomic data management. Moreover, faster and more efficient computing algorithms allow for privacy preserving analysis. Strengthening data security and governance frameworks will be vital as genomic testing expands.

Global Personalized Genomics Market Regional Insights

North America is expected to be the largest market for the global personalized genomics market during the forecast period, accounting for over 40% of the market share in 2023. The growth of the market in North America is attributed to the high adoption of genomic technologies, investments in precision medicine research, and presence of leading genomics companies in the region.

The Europe market is expected to be the second-largest market for the global personalized genomics market, accounting for over 25% of the market share in 2023. The growth of the market in Europe is attributed to initiatives like the 100,000 Genomes Project in the UK, advancements in genomic medicine using big data and increasing funding for genomic research.

The Asia Pacific market is expected to be the fastest-growing market for the global personalized genomics market, with a CAGR of over 18% during the forecast period. The growth of the market in Asia Pacific is attributed to growing burden of diseases like cancer, favorable government policies for biotechnology and large target population.